haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 24:41 IST
  • 03 Jun 2024 13:14
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Recommendation of appointment of Director '.

    PDF · -
  • 28 May 2024 16:09
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 24 May 2024 10:37
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Investors/Analysts call

    PDF · -
  • 21 May 2024 17:00
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 18 May 2024 14:18
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2024

    PDF · -
  • 17 May 2024 18:46
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 17 May 2024 18:46
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 17, 2024, titled "Press Release".

    PDF · -
  • 17 May 2024 18:26
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 17, 2024, recommended Final Dividend of 6.75 per equity share.

    PDF · -
  • 17 May 2024 18:22
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024.

    PDF · -
  • 13 May 2024 17:34
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 11 May 2024 13:49
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 6676 Shares.

    PDF · -
  • 30 Apr 2024 18:13
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 30 Apr 2024 17:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 30 Apr 2024 17:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 29 Apr 2024 16:31
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Update on disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 submitted on 26-04-2024'.

    PDF · -
  • 26 Apr 2024 18:11
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 18 Apr 2024 16:36
    Insider / SAST

    Tau Investment Holdings Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    PDF · -
  • 08 Apr 2024 17:15
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.

    PDF · -
  • 08 Apr 2024 17:02
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

    PDF · -
  • 05 Apr 2024 14:55
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 27 Mar 2024 17:00
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 22 Mar 2024 13:58
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 09 Mar 2024 18:21
    Legal

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr Ranjit Shahani, Chairman of the company on March 09, 2024.

    PDF · -
  • 09 Mar 2024 14:44
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement for Postal Ballot

    PDF · -
  • 08 Mar 2024 16:10
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

    PDF · -
  • 07 Mar 2024 14:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 05 Mar 2024 17:52
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 43450 Shares.

    PDF · -
  • 29 Feb 2024 08:40
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 190000 Options.

    PDF · -
  • 22 Feb 2024 15:40
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Grant of 30000 Options.

    PDF · -
  • 12 Feb 2024 12:17
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 07 Feb 2024 18:34
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 07 Feb 2024 14:03
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for the quarter and nine months ended on December 31, 2023

    PDF · -
  • 06 Feb 2024 16:26
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 06 Feb 2024 16:26
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Press Release".

    PDF · -
  • 06 Feb 2024 16:08
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Feb-2024.

    PDF · -
  • 06 Feb 2024 16:02
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.

    PDF · -
  • 06 Feb 2024 15:53
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 06, 2024, declared Interim Dividend of 5.50 per equity share.

    PDF · -
  • 06 Feb 2024 15:49
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Narayan Saraf as Chief Financial Officer of the company w.e.f. February 23, 2024.

    PDF · -
  • 06 Feb 2024 15:46
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Dividend Updates

    PDF · -
  • 05 Feb 2024 13:33
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 107190 Shares.

    PDF · -
  • 02 Feb 2024 14:27
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of schedule of Analysts/Institutional investors meet'.

    PDF · -
  • 31 Jan 2024 15:29
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 17 Jan 2024 14:17
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 13 Jan 2024 11:51
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 '.

    PDF · -
  • 09 Jan 2024 17:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

    PDF · -
  • 05 Jan 2024 15:11
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 29 Dec 2023 17:46
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 27 Dec 2023 17:04
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 26 Dec 2023 17:53
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 25 Dec 2023 13:12
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries